BSD Med Corp. (fka PRSNQ)

[mightymoe]

she will blow big time!!!:: shortly!! till then let's keep up with the short records...


2015/09/02|PRSN|3900|100|17741|Q
http://regsho.finra.org/FNSQshvol20150902.txt

IMO PRSN is the



next mega mover: PRSN... @ 0.43'ish As of July 15, 2015, there were 4,016,323 shares of the Registrant’s common stock, $0.001 par value per share, outstanding.

http://perseonmedical.com/ company website!!

later Q10:: http://services.corporate-ir.net/SEC.Enhanced/SecCapsule.aspx?c=75162&fid=10222160


as it's an up and coming med tech company that has almost no market capitalization as of now...and is completely unknown and off any maps!!!

http://www.finviz.com/quote.ashx?t=PRSN


just had an RS and is coming out of a merger!!!!! geez take a loook at this chart!!!!... no volume??? let's put it on the map!!!

Aug-31-15 09:15AM Perseon Announces the Initiation of the First Multi-Organ in vivo Ablation Zone Study for MicroThermX(R) in Laparoscopic and Open Approaches GlobeNewswire

Aug-19-15 04:02PM PERSEON CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard;

9-Aug-2015 http://biz.yahoo.com/e/150819/prsn8-k.html

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tran


Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
As disclosed previously, on July 13, 2015, Perseon Corporation (the "Company") notified The Nasdaq Stock Market ("Nasdaq") that as of June 30, 2015, the Company's stockholders' equity was below the $2.5 million minimum required by Listing Rule 5550(b)(1) (the "Stockholders' Equity Rule"). The Company later received a letter from Nasdaq advising the Company that (i) it is not in compliance the Stockholders' Equity Rule and (ii) it has 45 days to submit a plan for regaining compliance with the Stockholders' Equity Rule.

In connection with the closing of the Company's registered offering of common stock and warrants on August 4, 2015, the Company received net proceeds of approximately $4.3 million. The Company believes that with the addition of these net proceeds it is now in compliance with the Stockholders' Equity Rule as of the date of this Current Report on Form 8-K.

Nasdaq will continue to monitor the Company's ongoing compliance with the Stockholders' Equity Rule, and if at the time of the Company's next periodic report the Company does not evidence compliance with the Stockholders' Equity Rule, then it may be subject to delisting.

09:15AM Perseon Launches INSPIRE 2017, a Dramatic Effort to Increase Adoption of Microwave Ablation to Fight Cancer GlobeNewswire

Jun-22-15 01:00PM Perseon Announces Reverse Stock Split Effective June 23, 2015 GlobeNewswire -15.15%

from the recent news and developments..
Apr-14-15 09:15AM Perseon Announces FDA Clearance for Specific Indication of Non-Resectable Liver Tumor Ablation GlobeNewswire

Apr-08-15 09:15AM Perseon's MicroThermX(R) Receives FDA Clearance for Laparoscopic Ablation Procedures GlobeNewswire




and for sure shorted::...:)

20150901|PRSN|1676|0|13860|Q http://regsho.finra.org/FNSQshvol20150901.txt
http://regsho.finra.org/regsho-Index.html